Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-26-003292

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
NATAN DAVID Director 2026-01-07 Grant or award · Option to Buy Common Stock +25,000 25,000 D
Loading xslF345X05/ownership.xml…